Court of Justice 16 July 2024, Case C-181/24, Genmab: Order of the Court (Eighth Chamber) of 16 July 2024 (request for a preliminary ruling from the Fővárosi Törvényszék – Hungary) – Genmab A/S (Reference for a preliminary ruling – Article 99 of the Rules of Procedure of the Court of Justice – Medicinal product for human use – Supplementary protection certificate for medicinal products (SPC) – Regulation (EC) No 469/2009 – Conditions for granting – Article 3(d) – First marketing authorisation (MA) – Medicinal products containing the same active ingredient being granted several MAs – Withdrawal of the prior MA)

Also known as